0
Summaries for Patients |

Hormone Treatment Beginning Near the Onset of Menopause FREE

[+] Article and Author Information

This article was published online first at www.annals.org on 29 July 2014.


The full report is titled “Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women. A Randomized Trial.” It is in the 19 August 2014 issue of Annals of Internal Medicine (volume 161, pages 249-260). The authors are S.M. Harman, D.M. Black, F. Naftolin, E.A. Brinton, M.J. Budoff, M.I. Cedars, P.N. Hopkins, R.A. Lobo, J.E. Manson, G.R. Merriam, V.M. Miller, G. Neal-Perry, N. Santoro, H.S. Taylor, E. Vittinghoff, M. Yan, and H.N. Hodis.


Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.


Ann Intern Med. 2014;161(4):I-19. doi:10.7326/P14-9027
Text Size: A A A

What is the problem and what is known about it so far?

After the onset of menopause, women may experience an increase in cardiovascular disease (CVD), such as coronary artery disease leading to heart attacks, in addition to hot flashes and other uncomfortable changes. Menopausal hormone therapy (MHT), sometimes called hormone replacement therapy, has been used to help alleviate symptoms of menopause, such as hot flashes. This therapy might also reduce a woman's risk for CVD, although a large clinical trial of this treatment in predominantly older menopausal women did not find such a benefit. It has been observed that women who were receiving MHT closer to the onset of menopause may have a lower rate of CVD. However, this information does not come from a clinical trial, which could more definitively establish whether such a benefit exists.

Why did the researchers do this particular study?

To find out whether starting MHT closer to the onset of menopause will reduce the risk for CVD.

Who was studied?

727 women aged 42 to 58 years who had onset of menopause within the past 3 years and did not have known CVD.

How was the study done?

Participants were randomly assigned to receive MHT (as 2 pills or a pill and a patch) or to receive placebo pills and patches. They continued MHT for up to 4 years. The researchers assessed whether the thickness of the carotid artery (a blood vessel in the neck) or the amount of calcium in the blood vessels of the heart changed during the study, because each of these factors is a marker of CVD. They also asked about menopausal symptoms, such as hot flashes.

What did the researchers find?

Thickening of the carotid arteries or the amount of calcium in the blood vessels of the heart did not differ between the treatment groups. The women who received MHT aspills and patches each reported fewer hot flashes than those who received only placebo.

What were the limitations of the study?

The study was too short to assess whether MHT might alter the number of clinical events (such as heart attack or stroke).

What are the implications of the study?

Four years of MHT started soon after menopause does not seem to alter the development of CVD, but more research is needed to assess longer-term treatment.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)